Skip to main content
. 2020 Feb 19;17(1):74–80. doi: 10.4274/tjps.galenos.2018.90582

Figure 1.

Figure 1

In vitro drug release study of marketed fast dispersible tablets (FDTs-1) of domperidonein (F1) 0.1 N HCl, (F2) SGF pH 1.2, (F3) Distilled water with 0.5% SLS, (F4) Distilled water with 1% SLS

FDTs: Fast dispersible tablets, SGF: Simulated gastric fluid, SLS: Sodium lauryl sulfate